Adam Feuerstein
American columnist
From Wikipedia, the free encyclopedia
Adam Feuerstein is an American blogger and columnist covering the biotechnology sector.
Adam Feuerstein | |
|---|---|
| Occupation |
|
| Nationality | American |
| Alma mater | Emory University |
Education
Adam Feuerstein completed a bachelor's degree in political science at Emory University.[1]
Career
Feuerstein covered business, technology, and commercial real estate for the San Francisco Business Times and the Atlanta Business Chronicle as an assistant managing editor.[1][2] He later wrote about business software for Upside.com. In March 2001, he joined TheStreet.com. From 2005 to 2006 he worked as a research analyst for a hedge fund before returning to TheStreet. He resigned in May 2017. Feuerstein accepted a position as a national biotechnology columnist at STAT in June 2017.[1]
Feuerstein is known for his style of reporting and his tweets to his large Twitter following.[3][4] He often shares "unabashed" views on Biotech stock and the Food and Drug Administration.[5]